Skip to main content
Top
Published in: International Journal of Clinical Oncology 4/2017

Open Access 01-08-2017 | Original Article

Patient perceptions of symptoms and concerns during cancer chemotherapy: ‘affects my family’ is the most important

Authors: H. Sasaki, K. Tamura, Y. Naito, K. Ogata, A. Mogi, T. Tanaka, Y. Ikari, M. Masaki, Y. Nakashima, Y. Takamatsu

Published in: International Journal of Clinical Oncology | Issue 4/2017

Login to get access

Abstract

Background

Cancer chemotherapy is associated with a variety of side effects/adverse events. It is very important that patients adhere to the planned chemotherapy regimen, which necessitates a minimum of side effects and that these side effects be kept under control. We have investigated patients’ concerns and symptoms during chemotherapy with the aim to seek solutions that will improve patients’ quality of life during chemotherapy.

Methods

Forty-nine patients with malignant diseases on parenteral antineoplastic agents were sequentially enrolled in this study. These patients completed a questionnaire consisting of 42 items related to non-physical concerns and 52 items of physical symptoms related to chemotherapy. Each patient was also asked to select the three items among these 94 items which affected him/her the most.

Results

The median age of the cancer patients was 62 years and the male-to-female ratio was 18:31. Among the non-physical concerns, the most frequently chosen concern was ‘affects my family or partner,’ followed by anxiety related to treatment. Regarding the physical symptoms, the most frequent complaints were fatigue, alopecia and constipation, while the most troublesome symptoms were nausea, poor taste and paresthesia. Overall, the most frequently expressed concerns were ‘affects my family or partner’ and anxiety related to treatment. Male patients suffered most from fever, fatigue and nausea, and female patients complained more of poor taste and gastrointestinal problems.

Conclusion

Patient perceptions of adverse events associated with cancer chemotherapy apparently have changed from physical symptoms to non-physical concerns. In our patient cohort ‘affects my family or partner’ was the most important concern. One important point to note is that female patients often complained of poor taste because this meant they were unable to cook well.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tominaga S (1992) Trends in cancer mortality, incidence and survival in Japan. Gan To Kagaku Ryoho 19:1113–1120PubMed Tominaga S (1992) Trends in cancer mortality, incidence and survival in Japan. Gan To Kagaku Ryoho 19:1113–1120PubMed
2.
go back to reference Coates A, Abraham S, Kaye SB (1983) On the receiving end–patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19:203–208CrossRefPubMed Coates A, Abraham S, Kaye SB (1983) On the receiving end–patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19:203–208CrossRefPubMed
3.
go back to reference Griffin AM, Butow PN, Coates AS et al (1996) On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7:189–195CrossRefPubMed Griffin AM, Butow PN, Coates AS et al (1996) On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7:189–195CrossRefPubMed
4.
go back to reference Carelle N, Piotto E, Bellanger A (2002) Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 95:155–163CrossRefPubMed Carelle N, Piotto E, Bellanger A (2002) Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 95:155–163CrossRefPubMed
5.
go back to reference Japan Society of Clinical Oncology (2010) Guidelines for appropriate use of antiemetic drugs, version 1. Kanehara, Tokyo Japan Society of Clinical Oncology (2010) Guidelines for appropriate use of antiemetic drugs, version 1. Kanehara, Tokyo
6.
go back to reference Tamura K, Aiba K, Saeki T et al (2015) CINV Study Group of Japan testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Clin Oncol 20:855–865CrossRefPubMed Tamura K, Aiba K, Saeki T et al (2015) CINV Study Group of Japan testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan. Int J Clin Oncol 20:855–865CrossRefPubMed
7.
go back to reference Bower JE, Bak K, Berger A et al (2014) American Society of Clinical Oncology: screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol 32:1840–1850CrossRefPubMedPubMedCentral Bower JE, Bak K, Berger A et al (2014) American Society of Clinical Oncology: screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. J Clin Oncol 32:1840–1850CrossRefPubMedPubMedCentral
8.
go back to reference Minton O, Richardson A, Sharpe M et al (2008) A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. Natl Cancer Inst 100:1155–1166CrossRef Minton O, Richardson A, Sharpe M et al (2008) A systematic review and meta-analysis of the pharmacological treatment of cancer-related fatigue. Natl Cancer Inst 100:1155–1166CrossRef
9.
go back to reference Yokoo M, Akechi T, Takayama T et al (2014) Comprehensive assessment of cancer patients’ concerns and the association with quality of life. Jpn J Clin Oncol 44:670–676CrossRefPubMed Yokoo M, Akechi T, Takayama T et al (2014) Comprehensive assessment of cancer patients’ concerns and the association with quality of life. Jpn J Clin Oncol 44:670–676CrossRefPubMed
10.
go back to reference Dancey J, Shepherd FA, Gralla RJ et al (2004) Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial. Lung Cancer 43:183–194CrossRefPubMed Dancey J, Shepherd FA, Gralla RJ et al (2004) Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial. Lung Cancer 43:183–194CrossRefPubMed
11.
go back to reference Coates A, Gebski V, Bishop JF et al (1987) Improving the quality of life during chemotherapy for advanced breast cancer; A comparison of intermittent and continuous treatment strategies. N Engl J Med 317:1490–1495CrossRefPubMed Coates A, Gebski V, Bishop JF et al (1987) Improving the quality of life during chemotherapy for advanced breast cancer; A comparison of intermittent and continuous treatment strategies. N Engl J Med 317:1490–1495CrossRefPubMed
Metadata
Title
Patient perceptions of symptoms and concerns during cancer chemotherapy: ‘affects my family’ is the most important
Authors
H. Sasaki
K. Tamura
Y. Naito
K. Ogata
A. Mogi
T. Tanaka
Y. Ikari
M. Masaki
Y. Nakashima
Y. Takamatsu
Publication date
01-08-2017
Publisher
Springer Japan
Published in
International Journal of Clinical Oncology / Issue 4/2017
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-017-1117-y

Other articles of this Issue 4/2017

International Journal of Clinical Oncology 4/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine